The short version of somatotroph fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-01-29. Anything still debated is marked as such rather than presented as settled.
Whether the drug improves hard clinical outcomes is not settled. No completed trial has shown a reduction in heart attacks or strokes among treated patients, although a dedicated cardiovascular outcomes study has been discussed in the literature. Investigators have also examined hepatic fat in people with HIV and fatty liver disease, cognitive measures in small cohorts, and changes in bone density. Regulatory labeling emphasizes monitoring of insulin-like growth factor 1 because supraphysiologic levels raise questions about tissue growth, and the clinical significance of that signal remains an open question rather than a demonstrated harm.
Binding of tesamorelin to the growth hormone-releasing hormone receptor on anterior pituitary somatotrophs activates a Gs protein pathway, raises cyclic AMP, and triggers release of stored growth hormone into the bloodstream. Because the analogue resists dipeptidyl peptidase-4, its plasma residence time exceeds that of native GHRH, producing a larger and more sustained secretory signal. The released growth hormone then acts on the liver and peripheral tissues to raise insulin-like growth factor 1, which feeds back on the hypothalamus and pituitary. This axis explains both the intended effects on fat distribution and the biological markers used to track them.
Studies of the compound rely on imaging and laboratory endpoints rather than on symptoms alone. Visceral adipose tissue is usually quantified by computed tomography or magnetic resonance imaging at the level of the abdomen, with waist circumference serving as a cheaper but less specific proxy. Blood work tracks insulin-like growth factor 1, fasting glucose, glycated hemoglobin, and lipid fractions. In the pivotal trials the imaging endpoint fell by roughly fifteen to twenty percent over six months, subcutaneous fat changed little, and the visceral fat returned toward baseline after treatment stopped, a pattern that shapes how clinicians discuss durability.
Published work tends to frame tesamorelin as a tool for studying the GHRH axis and as a compound with measurable effects on body composition. Reports often describe visceral adipose tissue as an endpoint, assessed by imaging rather than by inference. Analytical sections commonly describe liquid chromatography with tandem mass spectrometry to confirm identity and purity, because immunoassays may cross-react with related fragments. Where results diverge between studies, differences in assay choice, sampling timing, and population are frequent explanations offered. Whether effects persist after treatment stops remains an open question.
Tesamorelin binds the growth hormone–releasing hormone receptor on pituitary somatotroph cells. The receptor signals through the Gs protein, raising intracellular cAMP and activating protein kinase A. That cascade triggers release of stored growth hormone in pulses rather than a steady stream. Because the drug acts at the receptor that normally controls this process, its effect depends on the body's own signaling architecture rather than on a synthetic pathway. The resulting hormone profile reflects the timing of each pulse, not only its size.
Measured responses usually involve growth hormone and insulin-like growth factor 1, known as IGF-1. Growth hormone rises in bursts and is difficult to sample reliably, while IGF-1 shifts more slowly and can be assessed from a single blood draw. Studies therefore treat IGF-1 as the more practical pharmacodynamic marker. Both are indirect, showing that the receptor was engaged rather than that the peptide reached a particular concentration. Direct exposure measurement requires an assay aimed at the molecule itself.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized cake in single-use vials |
| Solubility class | Freely soluble in water | Reconstituted with sterile diluent before injection |
| Typical storage temperature | 2 to 8 degrees Celsius | Before reconstitution; protect from light |
| Typical analytical method | Reversed-phase high-performance liquid chromatography | Purity and related-substance testing |
| Identity confirmation | Mass spectrometry | Observed mass near 5.1 kDa for the intact peptide |
The surgical technologies business group designed and manufactured products for the diagnosis and treatment of ear, nose, and throat (ENT) diseases and cranial, spinal, and neurologic conditions. It also encompassed a surgical navigation division to design "StealthStation" systems, software, and instruments for computer assisted surgery (CAS) and a special intraoperative X-ray imaging system (3D fluoroscopy), known as the O-arm Imaging System. Many of the products are used for minimally-invasive surgical procedures. In 2016, the business unit was dissolved, and each site folded into new business groups.
Statins have a protective effect on blood vessels, and SSRIs such as fluoxetine may help symptoms, but the data is weak. PDE5 inhibitors, such as sildenafil and tadalafil, are used off-label to treat severe ischemia and ulcers in fingers and toes for people with secondary Raynaud's phenomenon; as of 2016, their role more generally in Raynaud's was not clear.
Allows performance beyond the usual pain threshold. Some painkillers raise blood pressure, increasing oxygen supply to muscle cells. Painkillers used by athletes range from common over-the-counter medicines which include NSAIDs (ibuprofen) to powerful prescription narcotics.
This helped the SENSEX crossed 7,000 points for the first time. 8000, 8 September 2005 – On 8 September 2005, the Bombay Stock Exchange's benchmark 30-share index – the SENSEX – crossed the 8,000 level following brisk buying by foreign and domestic funds in early trading. 9000, 9 December 2005 – The SENSEX on 28 November 2005 crossed 9,000 and touched a peak of 9,000.32 points during mid-session at the Bombay Stock Exchange on the back of frantic buying spree by foreign institutional investors and well supported by local operators as well as retail investors. However, it was on 9 December 2005 that the SENSEX first closed at over 9,000 points. 10,000, 7 February 2006 – The SENSEX on 6 February 2006 touched 10,003 points during mid-session. The SENSEX finally closed above the 10,000 mark on 7 February 2006. 20,000, 11 December 2007 – The SENSEX on 29 October 2007 crossed the 20,000 mark for the first time during intra-day trading, but closed at 19,977.67 points. However, it was on 11 December 2007 that it finally closed at a figure above 20,000 points on the back of aggressive buying by funds. 21,000, 5 November 2010 – The SENSEX on 8 January 2008 crossed the 21,000 mark for the first time, reaching an intra-day peak of 21,078 points, before closing at 20,873. However, it was not until 5 November 2010 that the SENSEX closed at 21,004.96, for its first close above 21,000 points. This record would stand for nearly three years, until 30 October 2013, when the SENSEX closed at 21,033.97 points.
=== Strength === Strong salts or strong electrolyte salts are chemical salts composed of strong electrolytes. These salts dissociate completely or almost completely in water. They are generally odorless and nonvolatile. Most group 1 and 2 metals form strong salts. Strong salts are especially useful when creating conductive compounds as their constituent ions allow for greater conductivity. Weak salts or weak electrolyte salts are composed of weak electrolytes. These salts do not dissociate well in water. They are generally more volatile than strong salts. They may be similar in odor to the acid or base they are derived from. For example, sodium acetate, CH3COONa, smells similar to acetic acid CH3COOH.
Sources: en.wikipedia.org
=== Necrotizing fasciitis === A study has found botox effective against necrotizing fasciitis caused by S. pyogenes in mice. Its mechanism of action is by blocking CGRP receptor of nerve cells, which trigger intense pain and activate CGRP cascade, which prevents the immune system attacks to control the pathogen. Botox blocks the CGRP cascade of nerve cells.
=== Cited texts === Dhillon, Karminder Singh (2009). Malaysian Foreign Policy in the Mahathir Era 1981–2003: Dilemmas of Development. NUS Press. ISBN 978-9971-69-399-2. Milne, R. S.; Mauzy, Diane K. (1999). Malaysian Politics under Mahathir. Routledge. ISBN 0-415-17143-1. Morais, J. Victor (1982). Mahathir: A Profile in Courage. Eastern Universities Press. OCLC 8687329. Sankaran, Ramanathan; Mohd Hamdan Adnan (1988). Malaysia's 1986 General Election: the Urban-Rural Dichotomy. Institute of Southeast Asian Studies. ISBN 981-3035-12-9. Stewart, Ian (2003). The Mahathir Legacy: a Nation Divided, a Region at Risk. Allen & Unwin. ISBN 1-86508-977-X. Wain, Barry (2010). Malaysian Maverick: Mahathir Mohamad in Turbulent Times. Palgrave Macmillan. ISBN 978-0-230-23873-2. James Chin & Joern Dosch. Malaysia Post Mahathir: a decade of change?. Marshall Cavendish. 2016. ISBN 9814677558
Club, described the film as "boneheaded" and "a perfect hate-watch" noting that Macdonald "slaps together some cheap, quick-cut montages gesturing at the modern surveillance state" but lacks the "feel for the pace or tension needed to keep the energy up in a film like this," and commenting that "The extended workout, either shot so far away that it looks like stock footage or so tight that it loses all sense of context, is never any more exciting than watching Gadot lope on a treadmill." Dennis Harvey, in a similarly negative review for Variety, wrote that the film "lacks the strong suspense or novelty necessary to elevate an overfamiliar concept" and criticized the acting, saying "Nor is Gadot a performer inclined to lend much more than athleticism to a role that could use some warmth and idiosyncrasy to color its rather generic action-hero gist." In a review for TheWrap, William Bibbiani wrote, "The Runner isn't much of a thriller. It isn't much of a movie. It would, however, be a hilarious episode of Taskmaster."
=== Assumed correlation between impact factor and quality === The journal impact factor was originally designed by Eugene Garfield as a metric to help librarians make decisions about which journals were worth indexing, as the JIF aggregates the number of citations to articles published in each journal. Since then, the JIF has become associated as a mark of journal "quality", and gained widespread use for evaluation of research and researchers instead, even at the institutional level. It thus has significant impact on steering research practices and behaviors. By 2010, national and international research funding institutions were already starting to point out that numerical indicators such as the JIF should not be considered as a measure of quality. In fact, research was indicating that the JIF is a highly manipulated metric, and the justification for its continued widespread use beyond its original narrow purpose seems due to its simplicity (easily calculable and comparable number), rather than any actual relationship to research quality. Empirical evidence shows that the misuse of the JIF—and journal ranking metrics in general—has a number of negative consequences for the scholarly communication system. These include gaps between the reach of a journal and the quality of its individual papers and insufficient coverage of social sciences and humanities as well as research outputs from across Latin America, Africa, and South-East Asia.
Hormones in cattle had been studied in North America for 50 years prior to the ban, accompanied by long-term use in over 20 countries. Canada and the United States asserted that these practices provided empirical evidence of long-term safety. The EU had already established other measures that restricted the import of North American beef. The primary North American product affected by the new ban was edible offal. A series of "hormone scandals" emerged in Italy in the late 1970s and early 1980s. The first, in 1977, was the discovery of premature puberty in northern Italian schoolchildren. Investigators cast suspicion on school lunches that used illegal hormone-treated meat. No concrete evidence was found–no samples of the suspect meals were available for analysis. In 1980 diethylstilbestrol (DES), another illegal synthetic hormone, was discovered in veal-based baby foods. Little or no scientific evidence supported these restrictions. However, consumer groups successfully influenced the European Parliament to enact regulations in the 1980s, and influenced public perceptions. In the US at the time, consumer organizations evinced little interest prior to the 1980s, and regulations were driven by a coalition of export-oriented industry and farming interests, opposed only by organic farming groups. Until 1980, the use of growth hormones was completely prohibited in Italy, Denmark, the Netherlands, and Greece. Germany, the EU's largest beef producer at the time, prohibited only exogenous growth hormones.
Sources: en.wikipedia.org
Recognizing and evaluating hyperthyroidism in pregnancy is a diagnostic challenge. Thyroid hormones are commonly elevated during the first trimester of pregnancy as the pregnancy hormone human chorionic gonadotropin (hCG) stimulates thyroid hormone production, in a condition known as gestational transient thyrotoxicosis. Gestational transient thyrotoxicosis generally abates in the second trimester as hCG levels decline and thyroid function normalizes. Hyperthyroidism can increase the risk of complications for mother and child. Such risks include pregnancy-related hypertension, pregnancy loss, low-birth weight, pre-eclampsia, preterm delivery, still birth and behavioral disorders later in the child's life. Nonetheless, high maternal FT4 levels during pregnancy have been associated with impaired brain developmental outcomes of the offspring and this was independent of hCG levels. Propylthiouracil is the preferred antithyroid medication in the 1st trimester of pregnancy as it is less teratogenic than methimazole.
== Efficacy == There is currently no standardized form of dry needling. There is a general scarcity of extensive research in the field. Many studies published about dry needling are not randomized, contain small sample sizes, and have high dropout rates. A review recommended the usage of dry needling, compared to sham or placebo, for decreasing pain immediately after treatment and at 4 weeks in patients with upper quarter myofascial pain syndrome. However, the authors caution that "the limited number of studies performed to date, combined with methodological flaws in many of the studies, prompts caution in interpreting the results of the meta-analysis performed". Similarly, a second review of dry needling found insufficient high-quality evidence for the use of direct dry needling for short and long-term pain and disability reduction in patients with musculoskeletal pain syndromes. The same review reported that robust evidence validating the clinical diagnostic criteria for trigger point identification or diagnosis is lacking and that high-quality studies demonstrate that manual examination for the identification and localization of a trigger point is neither valid nor reliable between examiners.
=== Disorders of glycogen metabolism === The most common disease in which glycogen metabolism becomes abnormal is diabetes, in which, because of abnormal amounts of insulin, liver glycogen can be abnormally accumulated or depleted. Restoration of normal glucose metabolism usually normalizes glycogen metabolism, as well. In hypoglycemia caused by excessive insulin, liver glycogen levels are high, but the high insulin levels prevent the glycogenolysis necessary to maintain normal blood sugar levels. Glucagon is a common treatment for this type of hypoglycemia. Various inborn errors of carbohydrate metabolism are caused by deficiencies of enzymes or transport proteins necessary for glycogen synthesis or breakdown. These are collectively referred to as glycogen storage diseases.
The issue was laid to rest when the Empress interceded with the Imperial Fitwarari whose forces had cornered Negus Teferi with a few of his men in his home and were preparing to make short work of them. The Kebur Zabagna also had one heavy machine gun company. It was commanded by Ethiopian graduates of Saint Cyr, the French military academy, at the time of the Italian invasion of Ethiopia. As a unit, the Imperial Bodyguard only participated in the Battle of Maychew (31 March 1936), but afterwards many of its members joined the various groups of the Ethiopian resistance. Following the return of Emperor Haile Selassie to Ethiopia in 1941, the Kebur Zabagna was reconstituted, and a Swedish military mission aided in its training. Men for the Kagnew Battalion, which fought in the Korean War, were drawn from the Imperial Bodyguard.
Sources: en.wikipedia.org
It mimics a natural hypothalamic signal that tells the pituitary to release growth hormone. The result is a rise in circulating growth hormone and, indirectly, in insulin-like growth factor 1. Over weeks of treatment this shift is associated with a selective decrease in fat stored inside the abdomen.
The primary measure is usually a cross-sectional abdominal scan that separates internal fat from fat just under the skin. Waist circumference and body weight are recorded as secondary measures because they are easy to obtain but do not distinguish the two fat compartments. Hormone and metabolic blood tests are collected alongside the imaging.
Available follow-up data indicate that visceral fat drifts back toward pretreatment levels once injections stop. The change is therefore best described as treatment-dependent rather than permanent. Investigators continue to debate whether intermittent or repeated courses would preserve any benefit.
It acts on the growth hormone–releasing hormone receptor, a Gs-coupled receptor found on pituitary somatotroph cells. Activation raises cAMP and prompts pulsatile hormone release.